Notably, when stratifying patients by median ITH, the range of ITH scores in the lower half of the distribution was much smaller than in the upper half, which suggests that there may be a distinct subtype within ER + /HER2− breast cancer with greater intra-patient homogeneity (Supplementary Fig. S10). This evidence concerns the gene ERBB2 and breast cancer.